Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3195 Target Snapshot

Sodium- and chloride-dependent glycine transporter 2 · SINGLE PROTEIN · Rattus norvegicus

87Compounds
5Assays
0Approved Drugs
94.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P58295. Use UniProt P58295 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P58295 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Sodium- and chloride-dependent glycine transporter 2 as ChEMBL target CHEMBL3195, mapped to UniProt P58295. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Sodium- and chloride-dependent glycine transporter 2
SINGLE PROTEIN · Rattus norvegicus
As of 2026-09-14
ChEMBL target ID
CHEMBL3195
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P58295
Sodium- and chloride-dependent glycine transporter 2
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Sodium- and chloride-dependent glycine transporter 2 is the right protein anchor across sources, using UniProt P58295 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelSodium- and chloride-dependent glycine transporter 2
UniProt AccessionP58295
Component TypeProtein
Sequence Length799 aa

Sodium- and chloride-dependent glycine transporter 2

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Sodium- and chloride-dependent glycine transporter 2, mapped to UniProt P58295. Sequence length is 799 aa.

Mapped IDP58295
Review nameSodium- and chloride-dependent glycine transporter 2
OrganismRattus norvegicus
Assay Mix

Activity Type Distribution

IC5094.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL1649969 6.96 IC50 110.0 Preclinical
CHEMBL28578 6.82 IC50 150.0 Preclinical
CHEMBL1649974 6.64 IC50 230.0 Preclinical
CHEMBL1649956 6.58 IC50 260.0 Preclinical
CHEMBL1649954 6.55 IC50 280.0 Preclinical
CHEMBL29608 6.55 IC50 283.0 Preclinical
CHEMBL29220 6.54 IC50 290.0 Preclinical
CHEMBL28746 6.48 IC50 330.0 Preclinical
CHEMBL1649588 6.47 IC50 340.0 Preclinical
CHEMBL2419425 6.47 IC50 340.0 Preclinical
Distribution

pChEMBL Value Distribution

8
5.0
19
5.5
18
6.0
9
6.5
0
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

5
Total Assays
29
Tested Compounds
2
Assay Types
Binding — 4 assays, 29 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 3 23 6.1
assay format 1 6 5.7
Functional — 1 assays, 26 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 1 26 5.9

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine